Alexandra Jacqueline (Sandy) Annala is the Chief Executive Officer for TheraBiologics Inc.
Sandy has extensive experience in government, corporate, and nonprofit management for biomedical research and development including management consulting, finance, budgets, contracts, regulatory affairs, fundraising and lobbying.
She received her Masters Degree from the Management of Information Sciences Program at the Claremont Graduate School in 1985, her Masters Degree from the USC Molecular Biology Program in 1990, and her Doctoral Degree from the USC Neural, Informational, and Behavioral Sciences Program in 1995. She pursued Postdoctoral Studies in Inducible Gene Expression at the University College London and Non-Invasive Medical Imaging of Gene Expression at the UCLA Medical School.
Sandy has served as Associate Research Professor of Neurosciences, Developmental, and Stem Cell Biology at The City of Hope Comprehensive Cancer Center, Associate Professor of Medical Physiology and Functional Imaging at Cleveland University of Los Angeles and Kansas City, Associate Professor of Gross Anatomy & Physiology at West Coast University School of Nursing, Director of Surgical Research at Cedars-Sinai Medical Center, and the Manager of Clinical Research at UCLA Neuropsychiatric Institute and Hospital.
She is co-author of thirty peer-reviewed publications, six patents, and three approved clinical trials primarily focused on the application of Human Neural Stem Cells for Precision Targeted Delivery of Therapeutic Agents to Cancer and Metastasies.